These findings are in line with our recent findings that there are no significant differences in circulating IL-6 and high-sensitivity C-reactive protein levels or ex vivo cytokine production in a cohort of patients with primary aldosteronism compared to matched hypertensive controls (22). The gene discussed is CRP; the disease is primary aldosteronism.